Farshad Banouei | Oncology Case Reports | Excellence in Innovation

Excellence in Innovation

Farshad Banouei
Hasheminjad Kidney Center, School of Medicine, Iran

Farshad Banouei

Affiliation Hasheminjad Kidney Center, School of Medicine, Iran University of Medical Sciences
Country Iran
Scopus ID 58574525400
Documents 5
Citation 2
h-index 1
Subject Area Oncology Case Reports
Event International Research Awards on Oncology and Cancer Research

Farshad Banouei is a researcher affiliated with Hasheminjad Kidney Center, School of Medicine, Iran University of Medical Sciences, Iran. The research recognition profile titled Excellence in Innovation highlights the importance of scientific contributions, interdisciplinary research, and innovation in advancing medical knowledge. The supplied publication records cover subjects including biomaterials, laser-based treatment approaches, dermatological interventions, nanomaterials, and clinical treatment research.

Abstract

Scientific innovation in medicine involves the development and evaluation of new materials, therapeutic techniques, diagnostic approaches, and clinical interventions. The supplied publication records associated with this research profile represent several areas of biomedical investigation, including hydrogel-based tissue expansion, laser-assisted treatment, photodynamic therapy, nanocrystal synthesis, and clinical management of medical conditions. These subjects demonstrate the interdisciplinary nature of contemporary biomedical research and the importance of collaboration across clinical medicine, materials science, and healthcare technology.

Keywords

Oncology Case Reports, Biomedical Research, Medical Innovation, Clinical Research, Laser Therapy, Photodynamic Therapy, Biomaterials, Hydrogel Polymers, Nanocrystals, Tissue Engineering, Cancer Research, Dermatological Treatment, Medical Materials Science, Therapeutic Development, Translational Medicine.

Introduction

Medical research continues to evolve through the integration of clinical knowledge, advanced materials, and innovative therapeutic technologies. Developments in biomaterials and tissue engineering contribute to the investigation of materials suitable for medical applications, while laser-based treatment methods provide additional approaches for managing selected clinical conditions. Similarly, nanomaterial research expands opportunities for investigating materials with specialized physical and chemical properties.

Research Profile

Farshad Banouei is presented in this recognition profile with an institutional affiliation at Hasheminjad Kidney Center, School of Medicine, Iran University of Medical Sciences, Iran. The research subject area identified for the profile is Oncology Case Reports. The supplied publication information provides a broader multidisciplinary scientific context, including biomaterials, clinical treatment procedures, laser applications, and nanomaterial synthesis.

Research Contributions

  • Biomaterials and tissue engineering: Research on methacrylate-based hydrogel polymers examines materials developed for tissue expansion applications in stomatology, contributing to the broader investigation of polymer-based medical materials.[1]
  • Clinical treatment research: Publications addressing infantile hemangiomas describe treatment procedures and clinical management considerations for a vascular condition encountered in pediatric medicine.[2]

Publications

The following selected bibliographic records were supplied for this academic profile. They are presented with their available journal, year, DOI, and contributor information. The records should not be interpreted as independently verified publications authored by Farshad Banouei, since the supplied contributor lists do not include that name.

  1. Hydrogel tissue expanders for stomatology. Part I. Methacrylate-based polymers.
  2. Infantile hemangiomas. Current treatment procedures | Infantilní hemangiomas. Současné tělečné protředky.
  3. Direct and indirect treatment of pain with lasers – Update 2016.

Research Impact

The supplied publications address research questions across several areas of biomedical science. Work on hydrogel polymers contributes to the scientific literature on biomaterials and their potential applications in tissue-related procedures. Investigations into laser-assisted treatment and photodynamic therapy provide clinical perspectives on therapeutic techniques, including approaches studied in dermatology and pain management. Nanocrystal synthesis research contributes to materials chemistry and the development of specialized nanoscale materials.

Award Suitability

The Excellence in Innovation recognition theme under the International Research Awards on Oncology and Cancer Research highlights scientific originality, research development, and contributions that may support progress in medical and biomedical disciplines.The multidisciplinary subjects represented in the supplied publication records offer potential areas for evaluating innovation in clinical treatment, biomedical materials, and therapeutic research. Relevant evaluation considerations may include:.

Conclusion

Excellence in medical innovation depends on sustained scientific investigation, interdisciplinary collaboration, and the translation of research findings into meaningful biomedical applications. The supplied publication records demonstrate the breadth of topics represented in contemporary biomedical and clinical literature, ranging from hydrogel-based materials and nanocrystal synthesis to laser-assisted therapies and photodynamic treatment.

References

  1. Google scholar profile. Hydrogel tissue expanders for stomatology. Part I. Methacrylate-based polymers. Journal of Materials Science: Materials in Medicine.
    https://scholar.google.com/citations?user=topjvN4AAAAJ&hl=en
  2. Šmucler, R., & Jenčová, J. (2016). Direct and indirect treatment of pain with lasers – Update 2016. Disease.
    Scopus
    https://www.scopus.com/authid/detail.uri?authorId=58574525400
  3. Bartůněk, V., Rak, J., Pelánková, B., Junková, J., Mezlíková, M., Král, V., Kuchař, M., Engstová, H., Ježek, P., & Šmucler, R. (2016). Large scale preparation of up-converting YF3:YbEr nanocrystals with various sizes by solvothermal syntheses using ionic liquid bmimCl. Journal of Fluorine Chemistry.
    https://doi.org/10.1016/j.jfluchem.2016.05.015
  4. Lippert, J., Šmucler, R., & Vlk, M. (2013). Fractional carbon dioxide laser improves nodular basal cell carcinoma treatment with photodynamic therapy with methyl 5-aminolevulinate. Dermatologic Surgery.
    https://doi.org/10.1111/dsu.12242

Donglin Sun | Prostate Cancer | Best Researcher Award

Dr. Donglin Sun | Prostate Cancer | Best Researcher Award

Southern Medical University | China

AUTHOR PROFILE

Scopus

🔬SUN DONGLIN – MEDICAL DOCTOR IN ONCOLOGY 

📚EARLY ACADEMIC PURSUITS 

Sun Donglin began his academic journey at No.1 Middle School of Fuyang, Anhui Province (2005-2008). His strong foundation in science led him to pursue a Bachelor’s Degree in Clinical Medicine at Bengbu Medical College (2008-2013), where he developed a keen interest in oncology. His dedication and passion for medical research culminated in a PhD in Oncology through the Master-Doctor Continuous Program at the Affiliated Cancer Hospital of Guangzhou Medical University (2018-2023). He was recognized as an “Outstanding Graduate Student” and “Excellent Graduate”, a testament to his academic excellence and research contributions.

🏥PROFESSIONAL ENDEAVORS 

Sun Donglin’s clinical training and professional career reflect a steady progression in expertise:

  • 2013 – 2016: Surgical Resident, Third Affiliated Hospital of Sun Yat-sen University – Gained hands-on experience in surgical oncology.
  • 2016 – 2018: Urology Resident Physician, Shenzhen Hospital of Southern Medical University – Developed a specialization in urological oncology.
  • 2023 – Present: Urology Associate Chief Physician, Shenzhen Hospital of Southern Medical University – Achieved Associate Chief Physician Certification in 2020, demonstrating his leadership in urologic oncology and clinical excellence.

🔍RESEARCH FOCUS 

Sun Donglin’s research focuses on two critical areas in oncology:

  1. Mechanisms of Non-Canonical NF-κB Signaling in Renal Fibrosis – Investigating how alternative pathways of NF-κB contribute to fibrosis, which has significant implications for kidney disease treatments.
  2. Drug Resistance Mechanisms in Prostate Cancer – Exploring molecular resistance pathways in prostate cancer to enhance therapeutic strategies and overcome treatment barriers.

💡CONTRIBUTIONS TO SCIENTIFIC RESEARCH 

Sun Donglin has led and participated in several high-impact research projects:

  • Principal Investigator:

    • National Natural Science Foundation of China (Youth Program) – 300,000 RMB (2025-2027) (Approval No.: 82400789)
    • Guangdong Provincial Medical Science and Technology Research Fund – 10,000 RMB (2024-2026) (Approval No.: A2024317)
    • Southern Medical University National Natural Science Foundation Cultivation Program – 100,000 RMB (2024-2026) (Approval No.: 23H3AGZR02)
  • Key Participant in Major Research Projects:

    • National Natural Science Foundation of China Major Research Program Cultivation Project – 680,000 RMB (2020-2022) (Approval No.: 91949102)
    • National Natural Science Foundation of China General Program – 570,000 RMB (2019-2022) (Approval No.: 81874095)

🌍IMPACT AND INFLUENCE 🌍

Sun Donglin’s research has contributed to a deeper understanding of renal fibrosis mechanisms and drug resistance in prostate cancer. His work has the potential to improve therapeutic interventions and patient outcomes, particularly in treatment-resistant prostate cancer cases. His collaborations in major national projects highlight his role as an emerging leader in oncological research.

🏅ACADEMIC CITES AND RECOGNITION 

  • Recognized as an Outstanding Graduate Student and Excellent Graduate during his PhD.
  • His research findings are gaining recognition in top-tier oncology journals, further solidifying his influence in the field.
  • Contributions to multi-million RMB-funded research projects, showcasing his ability to secure competitive grants.

🌱LEGACY AND FUTURE CONTRIBUTIONS 

Sun Donglin’s work will shape the future of oncology therapeutics and urological oncology. His research on non-canonical NF-κB signaling could unlock new pathways for renal fibrosis treatment, while his studies on prostate cancer drug resistance could lead to novel therapeutic strategies.

Moving forward, he aims to:
✅ Expand research collaborations internationally to enhance the impact of his studies.
✅ Develop translational therapies targeting NF-κB signaling in fibrosis and prostate cancer.
✅ Mentor young oncologists and researchers to foster the next generation of medical scientists.

🌍CONCLUSION 

Dr. Sun Donglin is a rising leader in oncology research and urological oncology, with a strong foundation in both clinical practice and scientific innovation. His expertise in non-canonical NF-κB signaling in renal fibrosis and drug resistance in prostate cancer has positioned him as a key contributor to the advancement of cancer therapeutics.

 

📊🔬NOTABLE PUBLICATION:
  • Title: Serum RelB is correlated with renal fibrosis and predicts chronic kidney disease progression
    Authors: Sun, D., Xie, N., Wang, X., Wu, W., Li, X. Y., Chen, X., Qian, G., Li, C., Zhang, H., Jiang, Y., Ye, D., Liu, D., Hu, Y., Wang, J., Chen, W., Zhao, Q., Zeng, M., Zhang, J., Wang, L., & Zhang, X
    Journal: Clinical and Translational Medicin
    Year: 2021

 

  • Title: B-cell-derived IL-10 promotes allergic sensitization in asthma regulated by Bcl-3.
    Authors: Qian, G., Jiang, W., Sun, D., Sun, Z., Chen, A., Fang, H., Wang, J., Liu, Y., Yin, Z., Wei, H., Fang, H., & Zhang, X.
    Journal: Cellular & Molecular Immunology
    Year: 2023

 

  • Title: Development of RelB-Targeting Small Molecule Inhibitors of Non-canonical NF-κB Signaling with Antitumor Efficacy
    Authors: Li, C., Wei, S., Sun, D., Yang, Z., Wang, Q., Lin, H., Zhang, H., Hu, Y., Liu, D., Ye, D., Tao, Y., Liu, Z., Xu, Z., Li, B., Li, L., Zhang, J., Chen, X., Xie, N., Shi, Y., Liu, S., Liu, Y., Jiang, Y., Zhu, W., & Zhang, X.
    Journal: Molecular Therapy
    Year: 2025

 

  • Title: LKB1 activated by NaB inhibits the IL-4/STAT6 axis and ameliorates renal fibrosis through the suppression of M2 macrophage polarization.
    Authors: Liang, W., Wu, H., Long, Q., Lin, H., Lv, X., Ma, W., Wu, T., Ai, L., Zheng, Q., Guo, J., Chen, X., Guo, J., & Sun, D..
    Journal: Life Sciences
    Year: 2025

 

  • Title: Integrative analysis of potential diagnostic markers and therapeutic targets for glomerulus-associated diabetic nephropathy based on cellular senescence
    Authors: Sun, D., Wei, S., Wang, D., Zeng, M., Mo, Y., Li, H., Liang, C., Li, L., Zhang, J. W., & Wang, L
    Journal: Frontiers in Immunology
    Year: 2023